Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Marpai ( (MRAI) ) has issued an update.
On September 16, 2025, Marpai, Inc. announced the execution of a Securities Purchase Agreement with investor parties, dated September 10, 2025. This agreement marks a significant step in Marpai’s financial strategy, potentially impacting its market positioning and stakeholder relations.
The most recent analyst rating on (MRAI) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Marpai stock, see the MRAI Stock Forecast page.
Spark’s Take on MRAI Stock
According to Spark, TipRanks’ AI Analyst, MRAI is a Neutral.
Marpai’s overall stock score is primarily impacted by its weak financial performance, with ongoing losses and cash flow issues. While there are some positive developments, such as the relaunch of MarpaiRx and a new securities agreement, these are not enough to offset the financial challenges. Technical analysis and valuation also suggest caution, with mixed signals and unattractive valuation metrics.
To see Spark’s full report on MRAI stock, click here.
More about Marpai
Average Trading Volume: 12,519
Technical Sentiment Signal: Hold
Current Market Cap: $20.9M
See more data about MRAI stock on TipRanks’ Stock Analysis page.